Deals

News Photos

Paradigm Biopharmaceuticals Limited's (ASX:PAR) Intrinsic Value Is Potentially 45% Above Its Share Price
Click on the image below to view in Stereo 3D

Timothy Springer Just Bought 25% More Shares In Selecta Biosciences, Inc. (NASDAQ:SELB)
Selecta Biosciences, Inc. (NASDAQ:SELB) shareholders (or potential shareholders) will be happy to see that insider...
More Description
Image URL


Is Anixa Biosciences (NASDAQ:ANIX) In A Good Position To Deliver On Growth Plans?
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
More Description
Image URL


Could The AlloVir, Inc. (NASDAQ:ALVR) Ownership Structure Tell Us Something Useful?
Every investor in AlloVir, Inc. (NASDAQ:ALVR) should be aware of the most powerful shareholder groups. Generally...
More Description
Image URL


Caladrius Biosciences (NASDAQ:CLBS) Is In A Good Position To Deliver On Growth Plans
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
More Description
Image URL


How Much Of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Do Institutions Own?
Every investor in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) should be aware of the most powerful shareholder...
More Description
Image URL


Is Sarepta Therapeutics (NASDAQ:SRPT) Weighed On By Its Debt Load?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
More Description
Image URL


When Will Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Turn A Profit?
With the business potentially at an important milestone, we thought we'd take a closer look at Alnylam...
More Description
Image URL


e-therapeutics (LON:ETX) Is In A Good Position To Deliver On Growth Plans
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
More Description
Image URL


Paradigm Biopharmaceuticals Limited's (ASX:PAR) Intrinsic Value Is Potentially 45% Above Its Share Price
In this article we are going to estimate the intrinsic value of Paradigm Biopharmaceuticals Limited (ASX:PAR) by...
More Description
Image URL

 
 
 
vlrPhone
vlrFilter
vlrMemos

Project of very low consumption, radiation and bitrate softphones
Multifunction Audio Filter with Remote Control
App to measure the quality of the voice
More Information
Free the Animation VR
AR

Play to reveal 3D images and 3D models
More Information

WhmSoft Moblog
Copyright (C) 2006-2021 WhmSoft
All Rights Reserved